<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82345">
  <stage>Registered</stage>
  <submitdate>13/10/2007</submitdate>
  <approvaldate>17/10/2007</approvaldate>
  <actrnumber>ACTRN12607000530426</actrnumber>
  <trial_identification>
    <studytitle>Tai Chi and Qigong for metabolic syndrome and diabetes control</studytitle>
    <scientifictitle>A pilot study on the efficacy, feasibility and acceptability of a Chinese medical exercise intervention program consisting of Tai Chi and Qigong in reducing indicators of risk of metabolic syndrome and Type 2 diabetes in adults with elevated blood glucose</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Indicators of metabolic syndrome and glycemic control.</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Metabolic disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Participants attended Tai Chi/Qigong group training classes for 1 to 1.5 hours 3 times a week for 12 weeks.</interventions>
    <comparator>Nil</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Prevention</interventioncode>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Changes in indicators of metabolic syndrome including body mass index (BMI), waist circumference, blood pressure, fasting blood glucose, triglycerides and high density lipoprotein-cholesterol (HDL-C).</outcome>
      <timepoint>Assessed immediately prior to and after the intervention.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Changes in other indicators of diabetes control including HbA1c, fasting insulin, 2 hour blood glucose, 2 hour blood insulin, total cholesterol, low density lipoprotein-cholesterol (LDL-C); and derived estimates from the blood glucose and insulin, including insulin resistance, metabolic clearance rate and beta cell function.</outcome>
      <timepoint>Assessed immediately prior to and after the intervention.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Changes in psychological measures including stress, depression, self-efficacy for physical activity, and social support for physical activity.</outcome>
      <timepoint>Assessed immediately prior to and after the intervention.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Changes in indicators of strength, general health and well-being including leg strength, diabetic symptoms, and quality of life.</outcome>
      <timepoint>Assessed immediately prior to and after the intervention.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Changes in behaviour measures including physical activity.</outcome>
      <timepoint>Assessed immediately prior to and after the intervention.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Had elevated blood glucose (&gt; 5.6 mmol/L and &lt; 7 mmol/L) but had not been diagnosed with type 2 diabetes, were living in the Brisbane area, were not on medication for blood glucose.</inclusivecriteria>
    <inclusiveminage>30</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>64</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Medical condition which contraindicates participation in physical activity as suggested by the American College of Sports Medicine 2000; unwilling or unable to attend three sessions/week for 12 consecutive weeks.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>After priliminary eligibility screening by telephone, potential participants were referred to GP for obtaining clearance to participate. Consent forms were obtained from all participants prior to baseline assessment.  This is a one group pre- and post intervention study, so no group allocation.</concealment>
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>29/08/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>11</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>4072</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>The University of Queensland</primarysponsorname>
    <primarysponsoraddress>St Lucia QLD 4072</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Diabetes Australia Research Trust</fundingname>
      <fundingaddress>5th Floor
39 London Circuit
Canberra City ACT 2600</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To preliminarily evaluate the effects of the program on primary outcomes (indicators of metabolic syndrome and diabetes control), and to investigate the feasibility and acceptability of both the program and the methods to be used in the main study.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Human Research Ethics Committee at the University of Queensland</ethicname>
      <ethicaddress>University of Queensland
St Lucia QLD 4072</ethicaddress>
      <ethicapprovaldate>24/02/2005</ethicapprovaldate>
      <hrec>HMS05/24/2</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Liu Xin</name>
      <address>School of Human Movement Studies, the University of Queensland
St Lucia QLD 4072</address>
      <phone>+61 7 33656463</phone>
      <fax />
      <email>liuxin@hms.uq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Liu Xin</name>
      <address>School of Human Movement Studies, the University of Queensland
St Lucia QLD 4072</address>
      <phone>+61 7 33656463</phone>
      <fax />
      <email>liuxinqg@hotmail.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Liu Xin</name>
      <address>School of Human Movement Studies, the University of Queensland
St Lucia QLD 4072</address>
      <phone>+61 7 33656463</phone>
      <fax />
      <email>liuxin@hms.uq.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>